$BPTH

HOUSTON, May 22, 2025 ( GLOBE NEWSWIRE ) -- Bio-Path Holdings, Inc., BPTH a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer and obesity drugs, today announced that it will host a live ...